ID   253J-BV
AC   CVCL_7937
SY   253JB-V; 253J B-V; 253JBV; 253J-Bladder-V
DR   BTO; BTO:0004894
DR   ArrayExpress; E-MTAB-2770
DR   Cosmic; 846282
DR   Cosmic; 1082645
DR   Cosmic; 1938695
DR   GEO; GSM136239
DR   IARC_TP53; 30015
DR   KCLB; 80002
DR   Wikidata; Q54583655
RX   PubMed=7658585;
RX   PubMed=29732388;
CC   Part of: BLA-40 bladder carcinoma cell line panel.
CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC   Characteristics: Metastatic phenotype. Obtained after 5 serial passages of the parent cell line in the bladder of nude mice.
CC   Doubling time: 49 +- 5 hours (PubMed=7658585).
CC   Omics: Deep RNAseq analysis.
CC   Omics: Transcriptome analysis.
CC   Derived from metastatic site: Lymph node.
ST   Source(s): KCLB
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9
ST   D3S1358: 15
ST   D5S818: 10,12
ST   D7S820: 9
ST   FGA: 23,24
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_7935 ! 253J
SX   Male
AG   53Y
CA   Cancer cell line
RX   PubMed=7658585; DOI=10.1016/S0022-5347(01)66923-4;
RA   Dinney C.P.N., Fishbeck R., Singh R.K., Eve B., Pathak S., Brown N.,
RA   Xie B., Fan D., Bucana C.D., Fidler I.J., Killion J.J.;
RT   "Isolation and characterization of metastatic variants from human
RT   transitional cell carcinoma passaged by orthotopic implantation in
RT   athymic nude mice.";
RL   J. Urol. 154:1532-1538(1995).
RX   PubMed=29732388; DOI=10.3233/BLC-180167;
RA   Zuiverloon T.C.M., de Jong F.C., Costello J.C., Theodorescu D.;
RT   "Systematic review: characteristics and preclinical uses of bladder
RT   cancer cell lines.";
RL   Bladder Cancer 4:169-183(2018).